Atara Biotherapeutics(ATRA) - 2023 Q4 - Earnings Call Presentation

INVESTOR PRESENTATION Q4 2022 FEBRUARY 8, 2023 Nasdaq: ATRA Forward-Looking Statements This presentation and the accompanying oral presentation contain forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this presentation, including statements regarding our future results of operations and financial position, future transactions, business strategy, product candida ...